Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19
{{output}}
Objectives: Intracerebral hemorrhage/bleeding (ICH) after an infection with SARS-CoV-2 (COVID-19) treated with the Janus-kinase inhibitor baricitinib has not been reported. ... ...
